An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
Clinical trial NCT06443944 · AVAILABLE
Trial details
- NCT number
- NCT06443944
- Sponsor
- CG Oncology, Inc.
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.